Skip to main content
Skip to footer
Menu
Who We Are
Our Focus : Mitral Regurgitation
Our TSMVR Solution
News
Contact
fr
News
Follow Our Latest Developments and Achievements
HighLife’s TSMVR Technology successfully used for the first time in China
HighLife’s TSMVR System and Clinical Study progress featured at EuroPCR 2021
Peijia Medical and HighLife Enter Into a License and Technology Transfer Agreement for Trans-septalMitral Valve Replacement in Greater China
VI Partners invests in Highlife Medical
HighLife Closes a €32 Million Round B Financing
HighLife appoints Dr. Martin Rothman as independent member of the board
HighLife appoints Jose Calle Gordo as Chairman of the Board
HighLife closes €12.3 million financing round led by Sofinnova Partners
1
2
3
Top
